yes the nation what is the danger of the big pharma racket well i'm right in the middle of the storm as you might know we're doing something with your own body parts your own cells making personal cell therapy available and yet we have the big pharma f.d.a. on top of us and part of the problem is if you look at everybody's motivation for what we do we are motivated want to make a few dollars ok but how do you do it i've got a very basic way of living i have to take care of patients and try to get them better yeah of academia who is in there trying to develop new techniques and things but they really are into research and they have pharma who really has to make a living making money and so they have to mass produce a product and sell to and as many people as possible and what's their goal to keep selling a product so alternately if you think about it their goal is to keep you. maybe symptomatically healthier and better but never really necessary to cure you in fact you know there's a company hard vone who developed a medication that can cure hepatitis b. they made like twelve billion

we originate from but from the relationship that he has with big pharma in general with that with you know some of these companies companies basic luzhin in credit yeah well i'd have to jump into dr gottlieb's head to understand that but it's not unreasonable to believe that he's had a long history of involvement with pharmaceutical industry and the pharmaceutical industry in many respects has set up guidelines that are you know been put together to protect the public so that you don't make drugs in a manner that can make them dirty ok so if i was going to make cough syrup and i have this huge tag with gallons and gallons of stuff in it i don't want to expose it to the air or to the environment i want to make sure everything i put in this tank is sterile and you know at the end i'm going to be pretty sure that my cough syrup a sterile and the comedy is they want us to do the same thing with yourselves as a point of care surgical procedure well how about if i do surgery on your belly and i open it up i'm exposing you tons of air i use. crystal oids liquid formulas you know sailing the

major in maybe try to promise a tickle companies and basically that can the big pharma it's let's say pharmaceuticals themselves are essentially a more of a danger to the public and the way that the government treats illicit drugs to be. there i don't know if they're more of a danger than illicit drugs but they can be dangerous so if somebody has typical back pain we could put a some of their stem cells into the back and cure them and get them off opioids we could probably reduce fifteen to twenty percent of the whole opioid epidemic because a lot of the opioid epidemic they're taking legal drugs we have patients like that all the time the fact shot your buddy from baseball did a study on concussion and what he found is if you give a rat's tail vein injection of your stem cell the stronger vasser fraction those are the cells we take from the fat so they're mixed with stem cells red cells white so platelets all this stuff if you just give a minute jackson. that stuff their concussion goes away so we had a football player who has retired at thirteen concussions and he was with his daugh

crisis president trump is calling on the justice department to bring a federal lawsuit against big pharma companies who are abusing the law thank you very much for. your courage which up on the roof grows from the strong growth world in our country to screech and we can stop we can certainly make a big dent and with the overprescription of antibiotics and medicare discounts a group of hospitals are pushing their way into big pharma with civic are x. the new nonprofit generic drug company that's taking initiative to offer generic prescriptions at a cheaper cost. their priority lies in making drugs that have been on the f.d.a. shortage list and those that have higher prices because they have no competition now according to the journal of the american medical association brand name drugs make up a whopping seventy two percent of drug spending across the u.s. but as concerns continue to grow over the rising drug prices we may be seeing more hospitals turning to the not for profit generic drug companies in washington thera montecito r t. one. spittles boost up the cost of service resolder the

in terms of the work that you're doing and how you're being attacked basically by the empire of big pharma now so if the f.d.a. is set up to police drugs and devices and several years ago they decided that there's going to be this area of biologics particularly stem cells and we realized that if i grew a stem cell in the lab and they give it back to you that's probably a drug it's not your d.n.a. at long somebody else because there's an onus in a burden for me to prove that that cell works on you and it's safe for you ok so the f.d.a. then looked at our own personal cells and they said they set up these arbitrary guidelines to determine when is your cell a drug what they said is if you took cells from bone marrow which is in a liquid form as long as you don't change the character of the cell then it's not a drug and you can use it so people can harvest bone marrow spin it down and give it back to you even though there's not them a stem cells is not that effective ok but they said if you take that were cells from a tissue and then you separate those cells now you change the character of the

medicare for all really which everybody was telling him at the time when he was doing deals with the big pharma and the big hospitals and the big and sure as companies well i want to look at one story coming from those with medicare ok here's what medicare for all might mean in the context of how our system works here soaring bankruptcy rates signal quote a coming storm of broke elderly study finds the rate of people sixty five and over a filing for bankruptcy grew nearly two hundred four percent from one thousand nine hundred one to two thousand and sixteen a study published by the social science research that were found and the percentage of seniors among all u.s. bankruptcy filers increased by nearly five times over the same period researchers looking at data from the consumer bankruptcy project found that high health care costs combined with reduced incomes and a widespread decline of pensions are all contributing the growing trend of financially broken retirees so it's health care costs is the number one thing we'll get into that data ok care costs are killing people yes that's that is cor

about his main mission, how the fda cleared the app for the apple watch, the president's attack on big pharma and the deadly opioid epidemic engulfing our nation. plus, the latest on the trunk trade were, there's developments there, we are less than an hour to the closing bell, don't lose. leave. we will start the countdown. let us put up wells fargo stock. the stock is on the move. intraday spiking breaking news , tim sloan has just announced the company will cut 5210% of its workforce within the next three years. it has been trying so long for quite the time for the scandal ridden bank. it's been played by investigation in the accusation of bad-faith banking by its customers. that's the least of it. sloan has his work cut out for him. the stock is down nine years, down, i'm sorry, 9% year to date. it's at least gaining 1% at the moment. let's get to the trade warden news. the dow is powering through and just crushing it, hitting an all-time high at this hour. the money number for the record close, we are way above it, 26616. for those of you listening on sirius xm channel 116, 26680. stick

and very simple and yet it could put a big dent in some of the you know financial profit making a big pharma and so i'm not i'm sure that that exists yet but the reality is we can coexist. true but essentially you're part of it which seems to be that way at future orientation which is going to be about servicing the individual which is a treat. the individual as an individual not as something that can be cured with the mass produced products basically which you have been living with last hundred plus years the nature of our current establishment is very much sort of you know one one one medicine cures all approach right in this is part of what seems to be the new wave which is more about let's look at the individual and see what genetically d.n.a. history indicates to us about this person and how this person needs to be treated the i'm sure we're go into that way and there are some pharmaceutical companies looking at taking your cells and you know altering them into a drug so they can cure you of cancer different things they're very expensive novartis got a car t. cell approved they have tha

medicare for all really which everybody was telling him at the time when he was doing deals with the big pharma and the big hospitals and the big insurance companies well i want to look at one story coming from those with medicare ok here's what medicare for all might mean in the context of how our system works here soaring bankruptcy rates signal quote a coming storm of broke elderly study finds the rate of people sixty five and over a filing for bankruptcy grew nearly two hundred four percent from one thousand nine hundred one to two thousand and sixteen a study published by the social science research now are found and the percentage of seniors among all u.s. bankruptcy file.

you did not want to be beholden to big pharma or the insurance companies i assume.e exactly right. exactly. many people, when we were getting started, said why didn't you start off with going to pharma? why we are really excited, we wanted driver to be a platform for the patient, and we wanted to build alignment with those key stakeholders in that room when a patient comes out of treatment, and that's just two people, the patient and the doctor. we wanted to build our platform with the patient being the primary customer, with alignment with our partner centers, and now that we have done that, we are really excited to bring pharma in, but in highly patientaligned ways that can augment their options. emily: driver c.e.o. and cofounder with bloomberg's steven engle. coming up, bbg venture is tackling the diversity problem and making the best on companies big and small on startups up to amazon, we will hear from her next, this is bloomberg. ♪ ♪ emily: president of abc entertainment, c.e.o. of martha stewart's media company and ceo has worn many hats, and she has greenli

medicare for all really which everybody was telling him at the time when he was doing deals with the big pharma and the big hospitals and the big insurance companies well i want to look at one story coming from those with medicare ok here's what medicare for all might mean in the context of how our system works here soaring bankruptcy rates signal quote a coming storm of broke elderly study finds the rate of people sixty five and over a filing for bankruptcy grew nearly two hundred four percent from one thousand nine hundred one to two thousand and sixteen a study published by the social science research network found and the percentage of seniors among all u.s. bankruptcy filers increased by nearly five times over the same period researchers looking at data from the consumer bankruptcy project found that high health care costs combined with reduced incomes and a widespread decline of pensions are all contributing the growing trend of financially broken retirees so it's health care costs is the number one thing we'll get into that data ok health care costs are killing people yes that's that is

i think that big pharma got in there and you know and to the people or to president trump and the people who surround them and you know it's not surprising if you look at the environmental policy is that the administration they've all been added over to and astray and i think he did the same thing with the pharmaceutical robert kennedy thank you not only for your time tonight but for the work you do. also thank you for having me. mood. would not be enough it would suit rich. people as a way of all's from some guy who owns. i came back to the community. and people we all be astounded you know the road look out for me oh look out is over i will go towards him. just. the right. says. she's going to. receive money doesn't that give us all that. but if you don't. know we're going to this. up close the cut costs also i am not touching me in my life. i see moms have to die. but politicians do something. to put themselves on the line to get accepted or rejected. so when you want to be president or injury. or somehow want to be preached. to the right to be for us that's what i'm up for freedom or

there's no doubt in my mind that big pharma some of the responsibility for our current opioid crisis they were very active in the one nine hundred eighty s. and one nine hundred ninety s. in the early oughts to advertise opioids those both directly to consumers and to prescribe. in their marketing they minimized the risks of opioids in particular the addictive potential and they maximize the benefits in truth there's no evidence that opioids work for chronic pain long term and i don't believe manufacturers heavily marketed their used to prescribe and patients in the treatment of chronic pain which i think has directly contributed to the opioid crisis we're facing today so this six shows that deaths from pain killers have been steadily increasing in the u.s. in recent years killing tens of thousands to see all of the washington pain center john dombrowski sass off need to be prescribed with great care. each patient there were saying no that's the reason why the longevity of people united states has gone down for the sucker third year in a row it's because the opiate crisis it really i

big oil, big tobacco, big pharma, big guns. with justice gorsuch riding with the roberts five, they won nine out of 10 cases they weighed in on. since 2006, they have given the chamber more than three quarters of their total votes n. all civil cases they voted for the chamber position fully 90% of the time and in these 5-4 cases i highlighted, 100%. people are noticing. they describe the court's service to republican interests. to be in wrote green house said the republican appointed majority is committed to harnessing the supreme court to an ideological agenda. or instein described the new reality of today's supreme court polarized along partisan lines where it paralyzes institutions and the rest of society in a fashion we have never seen. and the american public knows it, too. the american public thinks the supreme court treats corporations more favorably than individuals compared to vice-versa by a 7-1 margin. 49% of americans think corporations get special treatment there. let's look at where you fit in. a republican politi

genetic testing company 23 and me has high hopes for a new partnership with big pharma. they are hoping to cure a range of disease. be sure to follow our breaking news network, tictoc, on twitter. this is bloomberg. ♪ emily: welcome back to the "best of bloomberg technology." i'm emily chang. defense contractor lockheed martin is looking for drone racing for the next advance in intelligence. we caught up with the company's chief technology officer keoki jackson at the techcrunch disrupt event in san francisco this week. >> this is the autonomy of a.i. challenges bringing back to the world of high speed play. we are partnering with video and drone racing league. if you see this on tv, we are raising the bar and raising the excitement level. we are challenging people out here at the conference today and around the world to develop the technology that will allow autonomous drones to meet and compete in a complicated race. emily: there will be no human drone intervention. keoki: once it goes, it has to work on its own. that is what we call edge computing, to navigate and com

and a lot of people blame big pharma, but only because it's their fault. ) yeah. >> jon: wow. >> stephen: according to the national safety council four out of five heroin users started by misusing prescription painkillers. it's right there on amazon: "customers who bought oxy also bought the mexican brown horse." now, one company that has profited massively off your pain is purdue pharmaceuticals, the makers of oxycontin, which is owned by the sackler family, seen here not giving a (bleep) about you. the sacklers and purdue have faced hundreds of lawsuits, including one right now by the state of colorado, which alleges that purdue pharma "downplayed the risk of addiction associated with opioids," "exaggerated the benefits," and "advised health care professionals that they were violating their hippocratic oath and failing their patients unless they treated pain symptoms with opioids." well, they have a point. after all, the hippocratic oath clearly states "first, do no harm, unless harming is extremely profitable! then harm! harm! harm!" purdue denies these

but because we took the risk a number of years ago where big pharma, remember this, more risk, we are ahead of the pack. >> all right let's keep that thought. the stock moved very big it would have been easier yesterday or monday. ceo of corbus pharmaceuticals. i urge caution only because i don't want people to move money even on good companies "mad money" is back after the break. >> all right fast, reliable internet is crucial. does it every go down? yes. can't do my job. business grinds to a halt. our gig-speed network not only downloads files up to 20 times faster, we go beyond fast with 4g backup for complete reliability. so if the unexpected happens... (snaps fingers) you stay up and running. we lost power... but not to that. i want that. (laughing) get fast, reliable internet and add tv and voice for a low price. call now. comcast business. beyond fast. >>> tonight we are taking a closer look at the marijuana boom i would say bubble depending on your perspective i said we could expect a lot of cannabis companies coming public through various different methods. m har dean, this i

big pharma, there's some capital there, but i think there's a need for more.roval process is very expensive. there's a royalty market that's also very large. traditionally, private capital hasn't operated in scale here. we think it may be changing. we're looking hard at it. >> are you going to launch something? >> i don't want to tip our hat, but i think we are going to do something here over time i think we've signalled enough that it is a space we're going into by the way, in our other areas, in private equity, we've made life science investments real estate, we're the second largest landlord with bio med in the life science office space. >> in the brief time we have left, let's hit the larger macro things, given your view. you were in china recently i think the financial roundtable there a week or so ago has there been any change in your viewpoint in terms of the chinese response and/or sense as to the seriousness of the situation with this ongoing war? really feels like it at this point, kpebetween the countriesn trade. >> what i'd say, i think the financi

fifirm covington & bururlin, where he worked as a lobbyist on behalf of clients from wall street, big pharma, and the weapapons industry. kyl l also worked to advance jue brett kavanaugh's suprpreme cout nomination through the senate. kyl has said he e will serve as arizona's junior senator until a special election i in 2020. in c chicago, jury selection is underway in the murder trial of white police officer jason van dyke, who's charged in the killing of 17-year-old african american laquan mcdonald in october of 2014. the killing was captured on a police dash cam video released under court order, which clearly contradicted police claims about the shooting. the video shows the teenagerer posing no threat and walking away from the officers before van dyke opened fire 16 times. on wednesday, about 100 protesters gathered near the cook county criminal courthouse as the trial got underway. this is activist williamam calloway. >> and if he is acquitted, it is not just going to be the south side, butjust the one every side of the state e that will rise up and will demand justice. amy: in louisian

. >> still sticking with the big pharma team. i am a buyer of pfizer. >> i don't like semis and i don't like usmc. >> big game saturday night twin cities line, and check it out, on the internet twitter and cbs will get you done. >> that does it for us stick >>> from the canyons of wall street to the heights of broad street, from the opening bell to the liberty bell, when the road is long, you roll up your sleeves, you get to work and you run with the bulls in the city of brotherly love, you fly with the birds it's the countdown to kickoff and cramer is coming home from philadelphia "mad money" starts right now

big pharma made a lot of money on this.u get them out of pain. we will judge your hospital. we will judge your emergency room based on your pain scores. that's how we were taught. and we were also told these medicines weren't all that addictive. we started handing out pills like crazy. 100 million americans have chronic pain. so, we did a disservice as doctors and as prescribers like we took data that was bullshit, and then we went forth with it said oh prescribe it to everyone, they won't get addicted. we know what we're doing. guess what, we didn't know what we were doing. ♪ you like her. she's always up on the latest trends. she got in early on the whole goat yoga thing. and her sunsets are always #nofilter. you like her. but you'd like her better if you made more money than she does. don't get mad at @just_marea. get e*trade. not in this house. 'cause that's no so-so family. that's your family. which is why you didn't grab just any cheese. you picked up new kraft expertly paired mozzarella and parmesan for pizzahyeah! k

big pharma players we are watching.is considering a second straight jump in drug prices. in korea watching -- october 10 is the date for an advisory to discuss the company's proposal. five similar cases and lost only one. in sydney, they posted an annual loss of nearly -- shery: the market open in japan just ahead. this is bloomberg. ♪ ♪ comcast business built the nation's largest gig-speed network. then went beyond. beyond chasing down network problems. to knowing when and where there's an issue. beyond network complexity. to a zero-touch, one-box world. optimizing performance and budget. beyond having questions. to getting answers. "activecore, how's my network?" "all sites are green." all of which helps you do more than your customers thought possible. comcast business. beyond fast. haidi: a very good morning. asia's major markets have just opened for trade. shery: good evening from new york. sophie: welcome to daybreak asia. haidi: our top story, asia-pacific stocks are set for a low start. they are the world's wors

if you look at the market caps of the three biggest beverage companies, the three big pharma companies and epilepsy and cancer drugs those are the top three and you take the top five cannabis companies and it's under $40 billion. double where was a week ago. there's huge room for growth longer term. it will take time. everyone is comparing evaluations to dotcom. there's no revenue there is no revenue today but all in the black market and canada alone, about $6.5 million growing to $8 billion. the market is there, just moving to legalization. >> thankprise your time, appreciate it. >> thanks very much. >>> president trump surveys the damage from hurricane florence and residents along the carolina coastlines begin the long road to rebuilding after the storm. we'll take you live to north carolina next. i'm ken jacobus, i'm the owner of good start packaging. we distribute environmentally-friendly packaging for restaurants. and we've grown substantially. so i switched to the spark cash card from capital one. i earn unlimited 2% cash back on everything i buy. and last year, i earned $36,000

i hope it's not because big pharma has a vice grip on this thing. i have seen it before and it worries me that that might be it. there is the irony in this. not only does that -- is that provision not included, but guess what is included? there is a provision in the bill that authorizes federal money to one of these advocacy groups. and guess what? it's an advocacy group funded by pharma. so i -- i really think that it's ironic that we're more comfortable giving federal money to one of these groups that can serve as a front organization for the opioid manufacturers that helped create this crisis than we are in requiring disclosure of the private funding for these groups. i'm really hopeful we can get it in the bill. in conference, i -- that we can either get the bill in conference, more importantly get that other provision out. by the way, if we're going to allow federal grant funding to these organizations, it should be all of them on a competitive basis, on merit. not name one that gets the money. there is something up there. there is something up

after building a multibillion dollar company she's taking on the big boys in the pharma industry.ug, right? for me it's about a billion patients. traditional drug companies recover their high research and development costs by charging high prices and selling them in countries that can afford to play those —— pay those rates, but she wants to do the opposite, by selling drugs that cost less to many more people in less developed countries. it might sound like a daunting task but her confidence stems from her past failures. afterfailing to confidence stems from her past failures. after failing to get into medical school in india, she's studied brewing in australia but when she returned home she couldn't get a job because she was a woman. even after starting by o'connor, the road to success wasn't always smooth. i keep telling entrepreneurs that india is intrinsic to entrepreneurial success so don't fear failure entrepreneurial success so don't fearfailure —— by o'connor. endure failure and get to the finishing line. they have been put one step closer to the finishing line. along with

and big pharma, with the help from the majority leader, sought to hitch a ride on this very same opioid legislation to get an unrelated $4 billion gift. it is enough to make you gag and hopefully we got that stopped. passage of this bill today is one modest step that we can take but so much more is needed. that this bill even counts as progress demonstrates how far we have to go. and while this bill brings some transparency to the pharmacy counter, the transparency which is most needed is comprehensive legislation, like the transparency drug pricing act that i introduced, to shed some light on where the prices get set and that's by the manufacture who hides the whole process through discounts, rebates, and fees. now, we all know that president trump solved the problem with his rose garden press conference early in the summer. he announced that prices are going down, but i've yet to find anybody who's benefited from that announcement. in fact, the associated press just analyzed drug prices since that announcement and they couldn't find any company that had made any significant reduction

big pharma is endlessly creative when it comes to ways to game the system and pad its pockets. so, let's take the medicaid rebate program. drug manufacturers have to provide rebates or discounts to states as a condition of having their drugs covered by medicaid. states then share that discount with the federal government. manufacturers are supposed to give larger discounts for brand drugs, which are typically more expensive than generic ones. but true to form, some drug makers may have misclassified their drugs in order to shirk their obligation to provide that larger discount. leading to more than $1.3 billion in lost discounts from drug manufacturers from 2012 to 2016. people might remember this issue from when the maker of epipen misclassified the epipen as a generic drug. so administrator verma, how is cms tracking the classification of drugs in the medicaid rebate program to see if there are any misclassifications? >> so, first of all, in terms of the classifications, i will add, in terms of the medicaid rebates, that the affordable care act actually capped the amount of r

commerce is the biggest one for all, for big pharma, big guns, you name it. and with gorsuch riding with the roberts' five, the chamber won nine out of 10 case it is weighed in on. the roberts' five, since 2016, d given the -- 2006, had given a quarter of all their votes. they voted for the chamber's position fully 90% of the time. and in these 5-4 cases i've highlighted, 100%. people are noticing. veteran court watchers like jeffrey tuba and linda greenhouse and norm described the court's service to republican interests. tubin wrote that roberts served the interest of the contemporary republican party. greenhouse has said the republican appointed majority is committed to harnessing the supreme court to an ideological agenda. orinstein described the new reality of today's supreme court, it is polarized, along partisan lines in a way that pair less other political -- parallels other political institutions and the rest of society in a fashion we have never seen. and the american public knows it too. the american public thinks that the supreme court treats corpo

aulsen takes money from big pharma and devotes to he wrote health care regulations. est place to find him that a big pharmaceutical company. and that is where i went. i was prepared to stay there for weeks. it took seven minutes. i was so shocked when i saw him walking by, i will stop the camera. but, i got him. proof. gfoot, erikm me, bi paulsen really exists. when it comes to the adser's caller for the overall, talk about the dark money. guest: thank you for that question. in of the things that we see so many of the ads that people are being bombarded with is that people are not necessarily aware of who patriot majority usa is or americans for prosperity. many of the groups on the top 15 list have names that are not household names and the new groups are forming all the time postive connotations that people see these and they want to trust them because they do not know, are they being funded by liberals or conservatives, are they being funded by special interests or not, and we see that over and over again. the research says if you are a viewer that does not have an

for a big coal, big oil, big pharma, big guns, you name it.th justice gorsuch writing with the roberts five, the chamber won 9 out of 10 cases it weighed in on. if the roberts five since 2,006 has more than three quarters of their votes. this year and all civil cases, they voted for the chamber's position fully 90% of the time and then 5-4 cases i've highlighted, 100%. people are noticing. the federal court watchers describe the courts service to republican interest. he wrote that on the supreme court, roberts has served the interests of the contemporary republican party. greenhouse has said the republican appointed majority is committed to harnessing the supreme court to an ideological agenda. orenstein described the new reality of today's supreme court. it has polarized along partisan lines in a way that parallels other political institutions and the rest of society and the fashion we have never seen. and the american public knows i it. the american public thinks the supreme court treats corporations more favorably than individuals compared

they've invested in fsd pharma, this is their facility we're live from today. one of the bigs about legalization there may not be enough product to start. >> certainly exciting we'll have legalization, different provinces and different jurisdiction also have different levels of preparedness for retail we will see empty store shelves because we've seen every other place in the world that has legalization and there will be a lack of product over the first year many of the producers are ramping up production but there's still a lag for that to catch up >> reporter: market size has been tough to pin down as well, guys we've heard figures ranging from $4 billion to $10 billion in the first two years. one thing is for sure there will be a limited amount of product available in year one. things like edibles won't be able to be retailed until 2019 that's something a lot of producers are excited about. back to you. >> seems like you have a lot of product right there, kate. don't get lost in that >> it's your "i love lucy" moment >> reporter: it is >> kate rogers, thanks >>> don't forg

big, wealthy, east coast investors. and lead,lockchain apparently -- weed, apparently? how is that manifesting in puerto rico? cristina: the island is trying to build on that farm a foundation -- pharmaion it has. the governor has a degree in engineering. he wants to turn it into an innovation center for marijuana. he wants to make sure the laws are very clear. we are now seeing investment coming in. photograph a growth facility inside an old building, an old government building that has been rehabbed as a marijuana farm. nexgen hopescalled to be able to expand. carol: we will end this week on a lighter note. we want to talk about art basel. ,his has transformed the city making unsafe locations in the miami area safe and hip. jason: the company behind this thinks it may have the secret sauce to helping other cities. basel started in switzerland. the company behind it was getting a lot of requests from other cities to do what they did in miami in other places. was a huge part of turning miami into a town with many different neighborhoods full of arts, bringing miami back a little bit to the international scene. carol: a revival? neighborhoods: are places where you would go and hang ou

big things happen. we have to do it again. >> do you really see it though? >> i do. >> go ahead. >> i worked with john mccain on bringing down the cost of pharma prices, by bringing in drugs from other countries. there are other republicans on the bill. i hope that someone else will take the lead. we was the only republican on the honest ads act. i'm asking another republican to get on that bill. so you have a number of cases and senator sullivan went through some of them where we work across the aisle all the time, but we have to see more of it. when people are afraid of pissing off president trump so they continue over and work with us, that's a problem. so people have to rise to the occasion. >> let me move -- you are on the judiciary i do. i conflated both of your committees. my apologies this sunday morning. the democratic base is pretty upset at democratic leadership. they didn't like the deal th that -- they didn't like the deal that schumer cut with mitch mcconnell that fast tracked the judicial nominees. why shouldn't the base be upset with that? >> what matters is what happens in the next week at this hearing. and i think you're going to see some really

big far ma company that made billions of dollars selling the widely prescribed opioid of course say con tin. they've been granted a patent designed to treat opioid addiction. the patent issued to purr due pharmais a faster-acting drug that controls cravings, and given to people hooked on heroin or opioid painkillers. richard saxon is listed as one of the inventors. earlier this week, purr due pharma made $3.4 million while working on a nasal spray used to treat opioid overdoses. but purr due will not receive royalties from sales of the nasal spray. all this comes as purr due pharma faces hundreds of lawsuits that allege the company is fueling the opioid crisis, the epidemic that killed 48,000 people last year alone. >>> for centuries, art lovers and historians have been wondering what the mona lisa was hiding behind her famous smile. >> now one prominent u.s. fission claims to know the answer. >> and how about a sugar rush? we'll take you inside the bay area's latest pop-up museum with a candy coated spinel. a pair of bay area mayor many people living with diabetes monitor their blood glucose every day. which means they have to stop. and stick their fingers. repeatedly. today, life-changing t

big tobacco coming in. in fact recently imperial brands invested alongside us to a company called oxford can be mid to technologies. gw pharman a company working on cannabinoid research >> does the underlying price of the krob go down -- crop go down with new producers >> absolutely. cannabis is a modty like anything else. in canada it's slow going and the market is just turning on but in the u.s. we've had quite a bit of history with this most recently you'd see in oregon where wholesale prices drop by almost half so there's definitely going to be serious compression in the near future and that's why the real question is how will these producers be able to produce at marginal costs? and i think as it pertains to canada the question might be how realistic is that down the road for them to produce that marginal cost? >> at least in canada we have visibility on the law. in this country it's murky on what status they're going to take, at least on industrial hemp mcconnell has introduced this bill how much will it affect whether coke can do this in the states, for example? >> on the coke side, they're looking at it from a cbd po

big things happen. we have to do it again. >> do you really see it though? >> i do. i mean i work with senator mccain on bringing down the cost of pharmarices, by bringing in drugs from other countries. there are other republicans on that bill and i hope someone else will come and take the lead. he was sadly the only republican on the bill to take on the social media companies to make them put their ads out there. i'm asking another republican to get on that bill. so you have a number of cases -- and senator sullivan went through some of them -- where we work across the aisle all the time, but we have to see more of it. when people are afraid of upsetting president trump and they won't come over and work with us, it is a problem. people are going to have to rise to the occasion. >> let me move to the kavanaugh hearing. you are in judiciary. >> i am. >> i conflated your committees. my apologies. you know they're upset at democratic leadership. he didn't like the deal, they didn't like the deal chuck schumer cut with mitch mcconnell that in their minds fast-tracked some of the judicial nominees. why shouldn't the base be upset with that?

big board today, it is likes. a provider of mobile english educational services in china over the nasdaq celebrating the ipo. a bio-pharmaoned some of these bullish analyst notes this morning. one of them is amazon. goes to 2525 we're going to see courtney reagan later on this morning at the brick and mortar store they're opening in soho. >> that, plus a devastating piece. a fantastically well thought out piece by morgan stanley. it's almost as if these analysts have been saying, amazon is at war with everyone and they're going to win i've been talking to the chief operating officer of the m ware and i know david is not -- talk about the m ware, i'm talking about the -- >> right. >> they do a lot of on boarding for companies to amazon and i know microsoft doesn't want to hear this and google certainly not. i think amazon web services is pulling away here. everybody thought that -- there was a microsoft, thought azure was on the verge of catching up. no, the web services business is worth more than people realize it's the price cutting coming in the food retail business that is going to shock people. >> jim, when you talk